Skip to content
  • CRO
        • Oncology
        • Dermatology
        • Ophthalmology
        • Gastroenterology
        • Neurology
        • Cardiology
        • Medical Device
        • Rare Disease
        • Digital Therapeutics
  • Technology
    • eSource
    • EDC
    • ePRO
  • Company
    • About Us
    • Careers
    • Podcasts
    • White Papers
    • Blog
    • Events
    • Press Room
    • Contact Us

Evans Blue

Back to search

Molecule Structure

Scientific Name

Evans Blue

Description of the Drug

Not Available

Source: DrugBank Online – DrugBank.com. Retrieved from

Brand Name(s)

Not Available

Company Owner(s)

Parke Davis Div Warner Lambert Co

Mechanism(s) Of Action

Not Available

Clinical Trial(s)

ClinicalTrials.gov – Evans Blue

Unichem Links

SureChEMBL SCHEMBL14533441
Nikkaji J529.689G
EPA CompTox Dashboard DTXSID1048253
DrugCentral 3217
rxnorm EVANS BLUE
ZINC ZINC000098052857

Drugs A - Z

  • 3,3′,4′,5-Tetrachlorosalicylanilide
  • Abacavir
  • Abaloparatide
  • Abametapir
  • Abarelix
  • Abatacept
  • Abciximab
  • Abemaciclib
  • Abiraterone
  • Abiraterone Acetate
  • Abobotulinumtoxina
  • Abrocitinib
  • Acalabrutinib
  • Acamprosate
  • Acarbose
  • Acebutolol
  • Aceclofenac
  • Acefylline
See the full list

CRO

  • Oncology CRO
  • Dermatology CRO
  • Ophthalmology CRO
  • Gastroenterology CRO
  • Neurology CRO
  • Cardiology CRO
  • Medical Device CRO
  • Rare Disease CRO
  • Digital Therapeutics CRO

Technology

  • eSource
  • EDC
  • ePRO

Company

  • About Us
  • Careers
  • Podcasts
  • White Papers
  • Blog
  • Events
  • Press Room
  • Contact Us

Sign up for Newsletter

Hidden
Thanks for subscribing! Select a topic of interest
Thanks for subscribing! Select a topic of interest

By submitting, you are agreeing to our terms and privacy policy
  • Privacy Notice
  • Terms and Conditions

© 2023 Vial. All rights reserved

Sign up for Newsletter

Be the first to know about clinical trials
near you

Hidden
Thanks for subscribing! Select a topic of interest
Thanks for subscribing! Select a topic of interest

By entering your email, you agree to our Terms and Condition & Privacy Policy